Purpose Unlimited’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Purpose Unlimited's CYTK Position: Q3 2026 in Review
Purpose Unlimited sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 562 shares — an estimated $48K sold.
Purpose Unlimited first reported a position in CYTK in Q2 2026 and held it in 1 quarter. The position peaked at $48K in Q2 2026. 468 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Purpose Unlimited reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
- Purpose Unlimited sold 562 Cytokinetics shares in Q3 2026, an estimated $48K.
- Purpose Unlimited first reported a position in Cytokinetics in Q2 2026 and held it in 1 quarter.
- Purpose Unlimited's Cytokinetics position peaked at $48K in Q2 2026.
- 468 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Purpose Unlimited's 13F filing for Q3 2026, filed 12 Nov 2026.